Abstract Relapse remains the leading cause of treatment failure after allogeneic stem cell transplantation (HCT) in acute myeloid leukemia (AML), yet predictors of late relapse remain poorly defined. We conducted a multicenter retrospective study including 388 patients with AML, representing a disease-specific cohort undergoing first HCT across six Scandinavian centers to evaluate the prognostic role of early T-cell chimerism assessed at three months post-HCT.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile